Salesforce (CRM) is expected to report strong fiscal third-quarter results this week amid elevated use cases for its entire product portfolio and demand for artificial intelligence solutions, ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Key Takeaways Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is ...

Major technology stocks are positioned for a strong year-end rally as artificial intelligence initiatives accelerate and ...

We recently published a list of 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...

Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...

Investing.com -- Wedbush analysts expect tech stocks to end the year on a positive note with a “Santa rally,” citing positive catalysts including deregulation under Donald Trump’s second term and ...

The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...

A potential Trump administration may ease regulations for self-driving vehicles, accelerating Tesla's progress ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after assuming coverage of the name. The firm added the company’s tau antibody for ...